NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Neuroone Medical Technologies's total debt was $121.90K at Mar 31, 2024. For fiscal 2023 it was $184.40K, up 54.2% from the year before. The highest annual figure on record is $1.26M in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Sep 30, 2023 | $184.40K | +54.2% |
| FY2022 | Sep 30, 2022 | $119.56K | -41.1% |
| FY2021 | Sep 30, 2021 | $202.90K | -83.9% |
| FY2020 | Sep 30, 2020 | $1.26M | +398.6% |
| FY2017 | Dec 31, 2017 | $253.00K | +406.0% |
| FY2016 | Dec 31, 2016 | $50.00K | +300.0% |
| FY2011 | Dec 31, 2011 | $12.50K | +19.0% |
| FY2010 | Dec 31, 2010 | $10.50K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $121.90K | -20.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $184.40K | +54.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $88.92K | -35.5% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $121.90K | -21.9% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $153.72K | -11.3% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $119.56K | -41.1% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $137.96K | -33.3% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $156.04K | -30.1% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $173.31K | -27.5% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $202.90K | -83.9% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $206.97K | -97.0% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $223.36K | -95.7% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $238.98K | -95.6% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $1.26M | +398.6% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $7.00M | +3328.6% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $5.21M | +10310.6% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $5.49M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $253.00K | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $204.07K | – |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | $50.00K | – |
See a number that looks wrong?